Delivra Health Brands Inc. DHB.V
Dividend Power Score
A single, comprehensive score designed to measure the true strength of a company’s dividend.
This score combines three essential pillars of dividend quality:
Consistency – Measures how reliable the dividend has been over time, focusing on payment history, stability, and the absence of cuts or suspensions.
Payability – Assesses the company’s financial ability to sustain its dividend, taking into account cash flow, earnings coverage, balance sheet strength, and overall financial health.
Growth – Evaluates the long-term growth of both the dividend and the company’s share price, highlighting businesses that consistently increase payouts while creating shareholder value.
Higher scores identify companies that have historically delivered dependable income alongside sustained dividend growth and long-term capital appreciation.
Ask Irving AI About DHB.V
Get to know the stock you’re researching through a simple conversation. Ask Irving about its Weiss rating, financial health, dividends, and potential risks — right from the stock page.
Get answers about this stock. Instantly.
Ask about the company’s financial health and its Weiss Safety, Reward, and Risk Ratings, with answers grounded in Weiss Ratings data.
Understand the numbers behind the rating.
Explore profits, cash flow, valuation, and dividends. Ask follow-up questions without leaving the stock page.
Put the stock’s strengths and risks in context.
Look beyond a single number. Explore rating changes and company trends to better understand the stock’s outlook.
Company Overview
Delivra Health Brands Inc. is a Canadian consumer packaged goods and health products company focused on wellness, pain management, sleep support, and cannabidiol (CBD)-related products. The company operates in the health and wellness industry through a portfolio of topical creams, supplements, and lifestyle products marketed primarily in North America. Delivra Health Brands trades on the TSX Venture Exchange under the symbol DHB.V and has historically positioned itself at the intersection of consumer health, over-the-counter wellness, and alternative health solutions.
The company’s primary revenue drivers have included sales from its branded consumer wellness products, licensing arrangements, and distribution partnerships. Its portfolio has included products marketed under brands such as Dream Water, LivRelief, and other wellness-oriented formulations targeting sleep support, pain relief, and recovery. Delivra Health Brands evolved from earlier cannabinoid-focused and health sciences initiatives into a broader branded consumer wellness platform through acquisitions, brand consolidation, and product commercialization efforts. Public disclosures indicate the company has emphasized science-backed formulations and retail distribution relationships as differentiating factors within a competitive wellness market.
Business Operations
Delivra Health Brands generates revenue primarily through the commercialization and distribution of branded health and wellness products. Its operations have centered around consumer packaged wellness goods, including topical pain relief products, sleep aids, and nutraceutical offerings. Key operating brands have included Dream Water, a sleep and relaxation beverage and supplement line, and LivRelief, a topical pain relief and recovery brand. The company has historically pursued both direct-to-consumer and retail distribution channels, including pharmacy, grocery, specialty wellness, and e-commerce platforms.
Operationally, the company has maintained activities in both Canada and the United States, with product distribution focused primarily on North American markets. Public filings and investor materials indicate that Delivra Health Brands has relied on manufacturing partnerships, intellectual property related to formulations and delivery systems, and strategic commercial relationships to scale product availability. The company has also been involved in licensing and commercialization arrangements tied to cannabinoid-related wellness applications, although the scope and materiality of these activities have varied over time based on regulatory conditions and market demand. Data regarding certain operational metrics and segment-level financial contributions remains limited in publicly available disclosures.
Strategic Position & Investments
Delivra Health Brands has pursued a strategy centered on expanding branded wellness offerings through acquisitions, product innovation, and broader retail penetration. A notable strategic development was the acquisition and integration of Dream Water Global Corp., which expanded the company’s sleep and relaxation category exposure. The company has also invested in expanding the reach of LivRelief products within pain management and active lifestyle markets. Management communications and public filings have consistently highlighted growth opportunities in non-prescription wellness products and functional health categories.
The company’s broader strategic direction has included participation in emerging health and cannabinoid-adjacent sectors, particularly where consumer demand intersects with natural health solutions and recovery products. Delivra Health Brands has emphasized formulations supported by scientific development and consumer testing as part of its market positioning. Public information also indicates ongoing evaluation of licensing opportunities, distribution expansion, and strategic partnerships aimed at increasing brand visibility and recurring revenue streams. Some investment and commercialization initiatives referenced in prior corporate announcements have not been fully detailed in later filings, and certain outcomes remain inconclusive based on available public sources.
Geographic Footprint
Delivra Health Brands is headquartered in Canada and maintains operational exposure across North America, with particular emphasis on the Canadian and United States consumer wellness markets. Its products have been distributed through retail, pharmacy, and online channels serving consumers seeking over-the-counter wellness and recovery solutions. The company’s commercial strategy has focused heavily on U.S. retail opportunities due to the scale of the health and wellness market and broader consumer demand for sleep and pain-management products.
The company’s international footprint outside North America appears limited based on publicly available filings and disclosures. While management has referenced broader market opportunities and potential international distribution arrangements, verified operational concentration remains primarily within Canada and the United States. Public corporate documents indicate that North American retail relationships and e-commerce channels remain central to the company’s commercial reach and growth initiatives.
Leadership & Governance
Delivra Health Brands has been led by executives with backgrounds in consumer packaged goods, health sciences, finance, and public markets. Corporate governance has been guided through a board and executive structure focused on scaling branded wellness products and pursuing strategic commercialization opportunities in regulated health-related categories. The company’s public communications have emphasized disciplined brand development, retail execution, and long-term shareholder value creation within the wellness sector.
Key executives and leadership figures identified in recent public disclosures include:
- Gord Davey – Chief Executive Officer
- Andrew Windsor – Chief Financial Officer
- Joseph K. Gabriele – Director
- John Duffy – Director
- David Schwede – Director
Leadership messaging in company filings and investor communications has consistently emphasized consumer wellness innovation, strategic brand expansion, and operational scalability. Certain executive and board appointments have changed over time, and some historical leadership data may vary across reporting periods based on available public filings.